| Levemir (insulin detemir rDNA origin) / Novo Nordisk |
NCT01548248: Efficacy and Safety of Levemir® Used as Basal Insulin |
|
|
| Completed | N/A | 631 | Europe | insulin detemir, insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 10/06 | 10/06 | | |
NCT01542424: An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus |
|
|
| Completed | N/A | 1889 | RoW | biphasic insulin aspart 30, insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 12/06 | 12/06 | | |
NCT01542489: Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos |
|
|
| Completed | N/A | 480 | Europe | insulin detemir, insulin aspart, human soluble insulin | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 04/07 | 04/07 | | |
NCT01542463: Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes |
|
|
| Completed | N/A | 4464 | Europe | insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 07/07 | 07/07 | | |
NCT01542476: The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction |
|
|
| Completed | N/A | 299 | Europe | insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 10/07 | 10/07 | | |
NCT00665093: Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes |
|
|
| Completed | N/A | 1569 | RoW | biphasic insulin aspart 30, NovoMix® 30, BIASP, insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 01/08 | 01/08 | | |
| Completed | N/A | 3637 | RoW | insulin detemir, Levemir®, NN304 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 01/08 | 01/08 | | |
| Completed | N/A | 1037 | Europe | insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 02/08 | 02/08 | | |
NCT00701155: Observational Study to Evaluate the Safety While Using Levemir® |
|
|
| Completed | N/A | 3593 | RoW | insulin detemir, Levemir® | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 03/08 | 03/08 | | |
| Completed | N/A | 2282 | RoW | insulin detemir, Levemir® | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 07/08 | 07/08 | | |
NCT00700765: Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes |
|
|
| Completed | N/A | 1531 | RoW | insulin detemir, Levemir® | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 07/08 | 07/08 | | |
NCT00671008: Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes |
|
|
| Completed | N/A | 400 | RoW | biphasic insulin aspart 30, NovoMix® 30, insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 09/08 | 09/08 | | |
NCT00655200: Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus |
|
|
| Completed | N/A | 2286 | RoW | insulin detemir, Levemir™ | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 09/08 | 09/08 | | |
NCT00738153: An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes |
|
|
| Completed | N/A | 798 | RoW | insulin detemir, Levemir® | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 05/09 | 05/09 | | |
NCT00698269: An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment |
|
|
| Completed | N/A | 5926 | RoW | insulin detemir, Levemir®, biphasic insulin aspart 30, insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 08/09 | 08/09 | | |
SAFE, NCT00789711: An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes |
|
|
| Completed | N/A | 3131 | RoW | biphasic insulin aspart 30, NovoMix® 30, BIASP, insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 08/09 | 08/09 | | |
NCT00670683: Observational Study of Patients With Diabetes Using Levemir® FlexPen® |
|
|
| Completed | N/A | 797 | RoW | insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 09/09 | 09/09 | | |
NCT00873639: Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues |
|
|
| Completed | N/A | 417 | Europe | insulin aspart, NovoRapid®, ANA, insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 11/09 | 11/09 | | |
| Completed | N/A | 51170 | Japan, Europe, RoW | insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 03/10 | 03/10 | | |
|
NCT00522210: Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 Diabetes |
|
|
| Completed | N/A | 18 | Canada | Detemir, Levemir, Novolin NPH or Humulin N | University of Calgary | Type 1 Diabetes | 03/11 | 03/11 | | |
| Completed | N/A | 580 | Europe | insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 04/11 | 01/13 | | |
| Completed | N/A | 40 | Europe | Insulin detemir, Insulin Levemir, Insulin NPH, Insulin Insulatard | Amsterdam UMC, location VUmc | Type 1 Diabetes | 12/11 | 12/11 | | |
NCT02204839: Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DM |
|
|
| Completed | N/A | 10 | Europe | Basal insulin dose, (Glargine, Lantus, Sanofi-Aventis, or Detemir, Levemir, Novo Nordisk) | Northumbria University, Newcastle University | Type 1 Diabetes Mellitus | 01/15 | 01/15 | | |
Basal21, NCT02360254: Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetes |
|
|
| Completed | N/A | 26 | Europe | Insulin degludec, Tresiba | University of Padova, Azienda Ospedaliera di Padova | Type 1 Diabetes Mellitus | 01/16 | 02/16 | | |
